Search Results - "Burkhardt UE"

A phase I trial of vaccination with lethally irradiated lymphoma cells admixed with granulocyte-macrophage colony-stimulating factor secreting K562 cells for the treatment of follicular lymphoma.

Authors: Jacobsen, Eric Plant, Ashley Redd, Robert et al.

Source: Leukemia & Lymphoma. Dec2024, Vol. 65 Issue 12, p1864-1874. 11p.

Cell activation-based screening of natively paired human T cell receptor repertoires.

Authors: Fahad, Ahmed S. Chung, Cheng Yu López Acevedo, Sheila N. et al.

Source: Scientific Reports. 5/17/2023, Vol. 13 Issue 1, p1-11. 11p.

Next-generation immunotherapeutic approaches for blood cancers: Exploring the efficacy of CAR-T and cancer vaccines.

Authors: Hushmandi, Kiavash Imani Fooladi, Abbas Ali Reiter, Russel J. et al.

Source: Experimental Hematology & Oncology. 5/17/2025, Vol. 14 Issue 1, p1-47. 47p.

Innovative combinatory approaches with dendritic cell-based vaccines: bridging preclinical insights and clinical challenges.

Authors: Motallebzadeh Khanmiri J Khani-Eshratabadi M Seyedmoharrami F et al.

Source: Clinical and experimental medicine [Clin Exp Med] 2026 Feb 14; Vol. 26 (1), pp. 154. Date of Electronic Publication: 2026 Feb 14.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer-Verlag Italia Country of Publication: Italy NLM ID: 100973405 Publication Model: Electronic Cited Medium: Internet ISSN: 1591-9528 (Electronic) Linking ISSN: 15918890 NLM ISO Abbreviation: Clin Exp Med Subsets: MEDLINE

Safety and efficacy of autologous cell vaccines in solid tumors: a systematic review and meta-analysis of randomized control trials.

Authors: Bastin, Donald J. Montroy, Joshua Kennedy, Michael A. et al.

Source: Scientific Reports. 2/27/2023, Vol. 13 Issue 1, p1-13. 13p.

Neoantigen cancer vaccines: a new star on the horizon.

Authors: Xiaoling Li Jian You Liping Hong et al.

Source: Cancer Biology & Medicine. Apr2024, Vol. 21 Issue 4, p274-311. 38p.

Allogeneic stem cell transplant in patients with chronic lymphocytic leukemia with 17p deletion: consult-transplant versus consult- no-transplant analysis.

Authors: Poon, Michelle L. Fox, Patricia S. Samuels, Barry I. et al.

Source: Leukemia & Lymphoma. Mar2015, Vol. 56 Issue 3, p711-715. 5p.

Improved disease markers suggest dual response in a patient with metastatic castration resistant prostate cancer and chronic lymphocytic leukemia following active cellular immunotherapy.

Authors: Cheng, Heather H. Soleau, Colleen Yu, Evan Y.

Source: Journal of Hematology & Oncology. 2015, Vol. 8 Issue 1, p1-5. 5p.

Cancer immune therapy for lymphoid malignancies: recent advances.

Authors: Klausen, Uffe Jørgensen, Nicolai Grønne Dahlager Grauslund, Jacob Handlos et al.

Source: Seminars in Immunopathology. Jan2019, Vol. 41 Issue 1, p111-124. 14p.

Wintrobe's Clinical Hematology

Authors: Robert J. Means, Jr George Rodgers Bertil Glader et al.

Resource Type: eBook.

Subjects: Blood--Diseases, Blood, Hematologic Diseases, Hematology--methods, MEDICAL / Hematology

Categories: MEDICAL / Hematology

Personalized cancer vaccines: bridging immune-oncology and precision medicine for advanced therapeutics.

Authors: Ye L Zhao G Ma J et al.

Source: Signal transduction and targeted therapy [Signal Transduct Target Ther] 2026 Jul 22; Vol. 11 (1). Date of Electronic Publication: 2026 Jul 22.

Publication Type: Journal Article; Review

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE

Immunotherapy in hematologic malignancies: past, present, and future.

Authors: Im, Annie Pavletic, Steven Z.

Source: Journal of Hematology & Oncology. 4/24/2017, Vol. 10, p1-10. 10p.

GIFT4 fusokine converts leukemic B cells into immune helper cells.

Authors: Jiusheng Deng Pennati, Andrea Cohen, Jonathon B. et al.

Source: Journal of Translational Medicine. 4/27/2016, Vol. 14, p1-12. 12p.

Therapeutic approaches in myelofibrosis and myelodysplastic/myeloproliferative overlap syndromes.

Authors: Sochacki, Andrew L. Fischer, Melissa A. Savona, Michael R.

Source: OncoTargets & Therapy. Apr2016, Vol. 9, p2273-2286. 14p.

Considerations for Combined Immune Checkpoint Modulation and Radiation Treatment.

Authors: Almo, Steven C. Guha, Chandan

Source: Radiation Research. Aug2014, Vol. 182 Issue 2, p230-238. 9p.

Immunotherapy for chronic lymphocytic leukemia in the era of BTK inhibitors.

Authors: Kharfan-Dabaja, M A Wierda, W G Cooper, L J N

Source: Leukemia (08876924). Mar2014, Vol. 28 Issue 3, p507-517. 11p.

Incorporating mRNA therapeutics into biological treatments of hematologic malignancies.

Authors: Hunia J Tomasik J Czerwik N et al.

Source: Frontiers in immunology [Front Immunol] 2025 Oct 22; Vol. 16, pp. 1680071. Date of Electronic Publication: 2025 Oct 22 (Print Publication: 2025).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Characterization of class-switched B cells in chickens.

Authors: von La Roche D Schumacher M Kohn M et al.

Source: Frontiers in immunology [Front Immunol] 2024 Nov 21; Vol. 15, pp. 1484288. Date of Electronic Publication: 2024 Nov 21 (Print Publication: 2024).

Publication Type: Journal Article

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

LMP1 and EBNA2 constitute a minimal set of EBV genes for transformation of human B cells.

Authors: Zhang J Sommermann T Li X et al.

Source: Frontiers in immunology [Front Immunol] 2023 Dec 19; Vol. 14, pp. 1331730. Date of Electronic Publication: 2023 Dec 19 (Print Publication: 2023).

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

Revolutionizing acute myeloid leukemia treatment: a systematic review of immune-based therapies.

Authors: Ebinama U George B

Source: Discover oncology [Discov Oncol] 2025 Jan 26; Vol. 16 (1), pp. 89. Date of Electronic Publication: 2025 Jan 26.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE